Related Experiment Video
Updated: Jun 7, 2026
09:13
Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
Published on: November 1, 2011
17.3K
The Current Progress in the Quest for Vaccines Against the Semliki Forest Virus Complex
Dorothy Hui Juan Cheong1, Bowen Yi2, Yi Hao Wong2
1Department of Microbiology and Immunology, Infectious Disease Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore City, Singapore.
Medicinal Research Reviews
|January 5, 2025
Summary
The Semliki Forest virus (SFV) complex causes outbreaks globally, necessitating effective vaccines. This review covers SFV pathogenesis and evaluates vaccine strategies, highlighting promising candidates for future development.
Area of Science:
- Arbovirology
- Immunology
- Vaccinology
Background:
- Semliki Forest virus (SFV) complex arboviruses cause global outbreaks of acute febrile illness.
- Transmission occurs through infected mosquito bites, leading to severe symptoms and increased mortality.
- No licensed vaccines currently exist for medically significant SFV complex viruses.
Purpose of the Study:
- To review Semliki Forest virus complex disease pathogenesis.
- To evaluate seven vaccine development strategies against SFV complex viruses.
- To discuss promising vaccine candidates and future development.
Main Methods:
- Review of current literature on SFV complex pathogenesis.
- Analysis of seven vaccine development strategies and their in vivo efficacies.
- Discussion of clinical trial candidates and future research directions.
Main Results:
- SFV complex viruses pose a significant global health threat due to re-emergence and outbreaks.
- Various vaccine strategies have been explored, with some showing promise in preclinical models.
- Several vaccine candidates have advanced to clinical trials, indicating progress in development.
Conclusions:
- Effective vaccines are crucial for controlling SFV complex outbreaks.
- Continued research and clinical evaluation are needed to develop licensed vaccines.
- Understanding pathogenesis and immune responses is key to successful vaccine design.
Related Concept Videos
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:24Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
01:18Yellow Fever
Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...